Anaemia results from the shortage of oxygen-carrying red blood cells that fuel body function.
Patients with impaired kidney function often suffer from anaemia because their kidneys no longer produce sufficient amounts of erythropoietin, a hormone that stimulates production of red blood cells. The anaemia associated with chronic kidney failure may exact a heavy toll on patients' health and well being. Amgen is a global biotechnology company that discovers, develops, manufactures and markets important human therapeutics based on advances in cellular and molecular biology. Amgen is headquartered in Thousand Oaks, CA, USA, with European headquarters in Lucerne, Switzerland. Furthermore, our research, testing, pricing, marketing and other operations are subject to extensive regulation by domestic and foreign government regulatory authorities.